XRP Adoption Expands to 6,000 US Pharmacies
NewsWellgistics Health incorporates XRP into its payment system across 6,000 US pharmacies, backed by a $50 million equity line from LDA Capital.

- Wellgistics Health launches XRP payments in pharmacies.
- Enhances speed, liquidity, and transparency in healthcare.
- XRP serves as payment and treasury asset.

The implementation highlights growing institutional interest in cryptocurrency, providing faster and cost-effective transactions. It marks a significant real-world application of blockchain technology in the healthcare sector.
Wellgistics Health Initiative
The initiative by Wellgistics Health, supported by a $50 million line of credit from LDA Capital, aims to transform healthcare payments with XRP’s integration. Wellgistics will use XRP to enhance payment speed and liquidity for 6,000 US pharmacies.
Brian Norton, CEO of Wellgistics Health, emphasizes the integration of blockchain technology to improve payment systems. The decision positions Wellgistics Health as a pioneering entity in healthcare, optimizing financial operations with XRP as a core asset.
“Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three.” — Brian Norton, CEO of Wellgistics Health
Implications for the Healthcare Industry
The payment transformation is expected to deliver real-time settlement, boosting efficiency in transactions between pharmacies, suppliers, and manufacturers. This move reflects growing interest in incorporating cryptocurrencies in traditional sectors.
XRP’s cost-effective framework, with less than $0.0002 per transaction, provides a stark contrast to traditional wire fees. Its integration proves advantageous for liquidity and financial control within pharmacy networks.
The broader implications could lead to increased adoption of XRP and similar technologies within the healthcare industry. While concerns regarding regulatory approval exist, the strategy could offer essential cost benefits and propel technological advances.
This initiative demonstrates how blockchain, through XRP, may continue influencing financial systems and operational efficiency. It highlights a potential shift in pharmaceutical distribution towards more scalable and agile financial frameworks.
More From Crypto News
Deribit Outages Highlighted Potential Risks for Bitcoin Hedgers
The first outage struck at 16:17 UTC, halting all derivatives trading platform-wide before service resumed at approximately 16:36 UTC, a gap of 19 minutes, acco...
Coinbase Gets $237M USDC: Stablecoins & Payments Asia Session Roundup
This is the Stablecoins & Payments Asia Session roundup covering 00:00 UTC to 11:59 UTC on November 22, 2026.
Developing: Chainflip Exploit Under Review
Developing: Coinlive could not independently verify a direct Chainflip statement regarding the alleged November 21, 2026 exploit.
Midnight (NIGHT) Rises 5.08% in 24 Hours: What the Data Shows
Midnight (NIGHT) traded at $0.04447256 as of 00:47 UTC on November 22, 2026, up 5.08% over the prior 24 hours, according to CoinGecko data.
China Stablecoin Payments: US Session Roundup, Nov. 21
This is the Stablecoins & Payments US Session Roundup for November 21, 2026, covering 12:00 UTC to 23:59 UTC.
Developing: Reports Say Moscow Exchange Plans Bitcoin, Ether and Tether Trading on December 1
Verification status: Moscow Exchange’s trading rules with the Bank of Russia had not been publicly confirmed.